(1 - 16 von 19
)
Janssen seeks EMA approval for Tremfya for PsA
www.zenopa.com
Janssen seeks EMA approval for Tremfya for PsA
Janssen seeks to expand Tremfya in arthritis - PharmaTimeswww.pharmatimes.com › news › janssen_seeks_to_ex...
www.pharmatimes.com
... that improve the signs and symptoms of the condition,” said Alyssa Johnsen, vice president, rheumatology disease area leader, Janssen.
J&J's Tremfya shows significant improvements for post-TNFi…www.pharmatimes.com › news › j_and_js_tremfya_...
www.pharmatimes.com
· “These results further our understanding of the efficacy of Tremfya to treat the varied manifestations of PsA,” said Alyssa Johnsen, ...
Janssen Submits Application Seeking U.S. FDA Approval Newswww.14news.com › prnewswire › › jan...
www.14news.com
· ... it is critical that their physicians have a breadth of treatment options to consider," said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
J&J halts late-stage Stelara trial in patients with lupus | S&P Global ...www.spglobal.com › latest-news-headlines › j-j-halts...
www.spglobal.com
· "Lupus patients are waiting for better treatments, which makes this outcome disappointing," Alyssa Johnsen, rheumatology disease area leader ...
Run/walk for mental health - Duluth News Tribune | News, weather, and...
www.duluthnewstribune.com
To sponsor, volunteer or get more information, contact Alyssa Johnsen at . AddThis Sharing Buttons. Share to Facebook Share to Twitter ...
Janssen Submits Application Seeking U.S. FDA Approval of KALBwww.kalb.com › prnewswire › › jansse...
www.kalb.com
· ... it is critical that their physicians have a breadth of treatment options to consider," said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
Salt Lake City Beginners Microblading Course – Ero Edge
eroedge.com
ABOUT · STAFF · CAREERS · SHOP. Loading Events. ×. This event has passed. Salt Lake City Beginners Microblading Course with Alyssa Johnsen at Ero Edge ...
Janssen Submits Application Seeking U.S. FDA Approval of KKCOwww.nbc11news.com › prnewswire ›
www.nbc11news.com
· ... it is critical that their physicians have a breadth of treatment options to consider," said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
Janssen Submits Application Seeking U.S. FDA Approval of KOLDwww.kold.com › prnewswire › › jansse...
www.kold.com
· ... it is critical that their physicians have a breadth of treatment options to consider," said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
Janssen Submits Application Seeking U.S. FDA Approval of WAFFwww.waff.com › prnewswire › › jansse...
www.waff.com
· ... it is critical that their physicians have a breadth of treatment options to consider," said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
Janssen Announces Discontinuation of Phase 3 LOTUS AP Newsapnews.com › article
apnews.com
· “Lupus patients are waiting for better treatments, which makes this outcome disappointing,” said Alyssa Johnsen, M.D., Ph.D., Vice President, ...
Janssen seeks FDA approval of ustekinumab for juvenile psoriatic ...www.healio.com › news › dermatology › janssen-se...
www.healio.com
· ... juvenile psoriatic arthritis, it is critical that their physicians have a breadth of treatment options to consider,” Alyssa Johnsen, MD, ...
Johnson & Johnson's arthritis drug shows promising results in ...www.pharmafile.com › news › johnson-johnson-s-a...
www.pharmafile.com
· Dr Alyssa Johnsen PhD, Vice President and Rheumatology Disease Area Leader of Janssen Research & Development, said: "PsA is a chronic ...
Janssen halts Phase III LOTUS trial of Stelara in SLE
www.clinicaltrialsarena.com
· Janssen Research & Development rheumatology disease area leader Alyssa Johnsen said: “Lupus patients are waiting for better treatments, ...
Janssen's Psoriatic Arthritis Drug Proves Long-Term Efficacy in...
www.chemdiv.com
Janssen's Psoriatic Arthritis Drug Proves Long-Term Efficacy in Two-Year Trial
sortiert nach Relevanz / Datum